Product
Elbasvir/Grazoprevir
1 clinical trial
6 indications
Indication
BCLC Stage B Hepatocellular CarcinomaIndication
BCLC Stage C Hepatocellular CarcinomaIndication
Hepatitis CIndication
Liver CarcinomaIndication
Hepatocellular Carcinoma AJCC v7Indication
Hepatocellular CarcinomaClinical trial
A Phase II Study of Pembrolizumab (MK-3475) in Hepatitis C Virus Positive and Negative Subjects With Advanced Hepatocellular Carcinoma Who Progressed on or Were Intolerant to First-Line Systemic TherapyStatus: Completed, Estimated PCD: 2023-08-09